Hashan spun out of Karst Peak Capital, where he was the Head of Healthcare, to found KP Rx, a specialist healthcare VC fund investing in biotech, medtech and medical devices companies domiciled in ANZ. Prior to Karst Peak Capital, Hashan was the Lead Healthcare Analyst at CLSA Australia and the Associate Healthcare Analyst at Macquarie Bank, covering ASX-listed healthcare companies. Preceding his entry into finance, he gained industry experience while working at Eli Lilly. He was also a Lieutenant in the Australian Army Reserves, serving from 2006 to 2014. Hashan holds a Bachelor of Science (Medicine), a Masters of Commerce (Finance) from UNSW and is a CFA Charterholder.
OUR EDITORIAL PROCESS
Market Index is committed to providing investors with clear, accurate, and transparent financial information.
To uphold our reputation as one of Australia’s most trusted sources, our journalists and content writers follow
a strict editorial process that was established by our in-house editor. Read more about our
Editorial Process.
News